摘要
人附睾蛋白4（HE4）是妇科恶性肿瘤领域近年研究的热点，日益增多的研究表明，HE4在卵巢癌的诊断及疾病监测方面具有很好的应用前景，HE4与CA125的联合检测，可提高诊断的敏感性和特异性，同时对卵巢癌的预后具有较好的提示作用。
Human epididymis protein 4 （HFA） is one of the most focused tumor markers in the research of gynecology malignancy. Increasing number of studies have shown that HE4 has a good application prospect in early diagnosis, differentiential diagnosis, and diseased surveillance of ovarian cancer. HE4 combined with CA125 can improve the sensitivity and specificity of the diagnosis, and may be helpful in the prognosis assessment of ovarian cancer. It may have wider application field.
出处
《实用肿瘤学杂志》
CAS
2013年第3期193-197,共5页
Practical Oncology Journal
